GLYCAEMIC CONTROL IN PAEDIATRIC TYPE 1 DIABETES: THE INTERPLAY OF DIABETES ACCEPTANCE AND MEDICAL TECHNOLOGIES

Type 1 diabetes (T1D) is characterised by complete insulin deficiency, placing a lifelong burden of insulin replacement therapy on patients.Children and adolescents are particularly vulnerable patients who must balance physical and emotional developmental changes with strict adherence to treatment regimens.Thus, they might benefit the most from advanced diabetes management technologies (ADMT), such as Continuous Glucose Monitoring Systems (CGMS) and insulin pumps.This study aimed to: (i) assess how different medical devices for managing T1D impact glycaemic control in young patients, and (ii) evaluate diabetes acceptance levels in this population group using a structured questionnaire.A total of 97 children and adolescents with T1D were recruited from Galati County.Many diabetes complications were observed, mainly diabetic neuropathy, neuropathy and nephropathy.ADMT use was associated with significant improvements in glycaemic control.Notably, diabetes acceptance scores were significantly associated with HbA1c improvement.CGMS demonstrated high efficacy regardless of patients' knowledge and attitudes, whereas insulin pump efficacy was influenced considerably by diabetes acceptance levels.These findings highlight the importance of tailoring therapeutic interventions to the characteristics of the patient and the devices used. RezumatDiabetul zaharat de tip 1 (T1D) este caracterizat de un deficit complet de insulin, impunnd pacienilor o povar pe via constnd n terapia de substituie cu insulin.Copiii i adolescenii sunt pacieni deosebit de vulnerabili, fiind nevoii s echilibreze modificrile fizice i emoionale ale dezvoltrii cu respectarea strict a regimurilor de tratament.Astfel, ei ar putea beneficia cel mai mult de tehnologiile avansate de gestionare a diabetului (ADMT), cum ar fi sistemele de monitorizare continu a glicemiei (CGMS) i pompele de insulin.Acest studiu a urmrit s: (i) evalueze modul n care diferite dispozitive medicale pentru gestionarea T1D au un impact asupra controlului glicemic la pacienii tineri i (ii) evalueze nivelurile de acceptare a diabetului n acest grup de populaie utiliznd un chestionar structurat.Un total de 97 de copii i adolesceni cu T1D au fost recrutai din judeul Galai.Au fost observate numeroase complicaii ale diabetului, n principal neuropatie diabetic, neuropatie i nefropatie.Utilizarea ADMT au fost asociate cu mbuntiri semnificative ale controlului glicemic.n special, scorurile de acceptare a diabetului au fost asociate semnificativ cu mbuntirea HbA1c.CGMS au demonstrat o eficacitate ridicat indiferent de cunotinele i atitudinile pacienilor, n timp ce eficacitatea pompei de insulin a fost influenat semnificativ de nivelurile de acceptare a diabetului.Aceste constatri evideniaz importana adaptrii interveniilor terapeutice la caracteristicile pacientului i la dispozitivele utilizate.

Authors

Publication Details

Journal
FARMACIA
Published
2025-04-29
DOI
https://doi.org/10.31925/farmacia.2025.2.14
Primary Topic
Diabetes Management and Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

GLYCAEMIC CONTROL IN PAEDIATRIC TYPE 1 DIABETES: THE INTERPLAY OF DIABETES ACCEPTANCE AND MEDICAL TECHNOLOGIES

Denisa Marin-Batir
FARMACIA
Diabetes Management and Research
article

GLYCAEMIC CONTROL IN PAEDIATRIC TYPE 1 DIABETES: THE INTERPLAY OF DIABETES ACCEPTANCE AND MEDICAL TECHNOLOGIES

Denisa Marin-Batir
article en

Abstract

Type 1 diabetes (T1D) is characterised by complete insulin deficiency, placing a lifelong burden of insulin replacement therapy on patients.Children and adolescents are particularly vulnerable patients who must balance physical and emotional developmental changes with strict adherence to treatment regimens.Thus, they might benefit the most from advanced diabetes management technologies (ADMT), such as Continuous Glucose Monitoring Systems (CGMS) and insulin pumps.This study aimed to: (i) assess how different medical devices for managing T1D impact glycaemic control in young patients, and (ii) evaluate diabetes acceptance levels in this population group using a structured questionnaire.A total of 97 children and adolescents with T1D were recruited from Galati County.Many diabetes complications were observed, mainly diabetic neuropathy, neuropathy and nephropathy.ADMT use was associated with significant improvements in glycaemic control.Notably, diabetes acceptance scores were significantly associated with HbA1c improvement.CGMS demonstrated high efficacy regardless of patients' knowledge and attitudes, whereas insulin pump efficacy was influenced considerably by diabetes acceptance levels.These findings highlight the importance of tailoring therapeutic interventions to the characteristics of the patient and the devices used. RezumatDiabetul zaharat de tip 1 (T1D) este caracterizat de un deficit complet de insulin, impunnd pacienilor o povar pe via constnd n terapia de substituie cu insulin.Copiii i adolescenii sunt pacieni deosebit de vulnerabili, fiind nevoii s echilibreze modificrile fizice i emoionale ale dezvoltrii cu respectarea strict a regimurilor de tratament.Astfel, ei ar putea beneficia cel mai mult de tehnologiile avansate de gestionare a diabetului (ADMT), cum ar fi sistemele de monitorizare continu a glicemiei (CGMS) i pompele de insulin.Acest studiu a urmrit s: (i) evalueze modul n care diferite dispozitive medicale pentru gestionarea T1D au un impact asupra controlului glicemic la pacienii tineri i (ii) evalueze nivelurile de acceptare a diabetului n acest grup de populaie utiliznd un chestionar structurat.Un total de 97 de copii i adolesceni cu T1D au fost recrutai din judeul Galai.Au fost observate numeroase complicaii ale diabetului, n principal neuropatie diabetic, neuropatie i nefropatie.Utilizarea ADMT au fost asociate cu mbuntiri semnificative ale controlului glicemic.n special, scorurile de acceptare a diabetului au fost asociate semnificativ cu mbuntirea HbA1c.CGMS au demonstrat o eficacitate ridicat indiferent de cunotinele i atitudinile pacienilor, n timp ce eficacitatea pompei de insulin a fost influenat semnificativ de nivelurile de acceptare a diabetului.Aceste constatri evideniaz importana adaptrii interveniilor terapeutice la caracteristicile pacientului i la dispozitivele utilizate.

FARMACIAVol. 73(2)
Openalex Percentile: Top 74%
Diabetes Management and Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.